Bilypsa Tablet (Saroglitazar): Lipid-Lowering Antidiabetic Tablet | For Diabetic Dyslipidemia, High Triglycerides & Fatty Liver Management
Bilypsa Tablet contains saroglitazar 4 mg, a medicine that acts on specific receptors involved in fat and glucose metabolism. It is used to manage diabetic dyslipidemia, a condition involving abnormal blood fat levels in people with type 2 diabetes. Saroglitazar helps reduce elevated triglycerides and supports improved lipid balance.
Product Overview
Bilypsa Tablet contains saroglitazar 4 mg, an oral medicine used to manage diabetic dyslipidemia, a condition involving abnormal blood fat levels in people with type 2 diabetes. It helps improve lipid balance, particularly elevated triglycerides. Saroglitazar acts on specific receptors involved in fat and glucose metabolism. Confirm the strength and formulation on the product packaging before relying on product-specific details.
Composition of Bilypsa Tablet
The active ingredient in Bilypsa Tablet is saroglitazar, commonly available in a 4 mg strength. Saroglitazar belongs to a class of medicines known as dual PPAR-alpha and PPAR-gamma agonists. These receptors play important roles in regulating fat metabolism and glucose balance.
How Bilypsa Tablet Works
Saroglitazar acts on two types of peroxisome proliferator-activated receptors (PPAR-alpha and PPAR-gamma).
PPAR-alpha activity: Helps regulate fat metabolism and reduce elevated triglyceride levels.
PPAR-gamma activity: Influences glucose and lipid metabolism, supporting metabolic balance.
Through these actions, saroglitazar helps improve certain abnormal lipid measurements, especially triglycerides, in suitable adults with diabetic dyslipidemia.
Role in Lipid Management
Diabetic dyslipidemia can involve high triglycerides, low HDL cholesterol (often called good cholesterol), and other changes in blood fat levels. These changes may occur alongside type 2 diabetes and can require ongoing monitoring.
Bilypsa Tablet may be included in a treatment plan to improve lipid levels when clinically appropriate. Its role depends on the person's blood test results, overall metabolic health, and the treatment approach selected by their healthcare professional.
Relationship Between Glucose and Fat Metabolism
Glucose and fat metabolism are closely connected. Insulin resistance can affect how the body processes both glucose and fats, contributing to changes in triglyceride and cholesterol levels.
Saroglitazar acts on receptors involved in these processes. However, Bilypsa Tablet should not be considered a replacement for other diabetes medicines, dietary changes, physical activity, or lipid-management treatments unless a healthcare professional specifically adjusts the treatment plan.
Administration and Formulation
Bilypsa Tablet is an oral tablet. The commonly listed strength is 4 mg, but the exact product details should be confirmed from the packaging. Follow the recommended schedule and instructions provided by your healthcare professional.
Monitoring During Treatment
Blood tests may be used to monitor triglycerides, cholesterol, glucose control, and other relevant health measurements. These results help a healthcare professional assess how well the treatment is working and whether the overall management plan needs adjustment.
Importance of Product Verification
Before publishing product details, confirm the active ingredient, strength, manufacturer, and locally approved indications against the actual Bilypsa Tablet packaging or official product information. This helps ensure that the information accurately reflects the specific product being described.
Precaution
Follow the Recommended Dose
Take Bilypsa Tablet according to healthcare professional guidance. Do not change the dose or treatment schedule on your own.
Monitor Liver Health
Inform your healthcare professional about any liver problems before starting treatment. Liver function tests may be recommended during use.
Check Kidney Health
Share your kidney health history, as it may affect whether saroglitazar is suitable for you.
Pregnancy and Breastfeeding
Seek professional guidance before using Bilypsa Tablet during pregnancy, when planning pregnancy, or while breastfeeding.
Monitor Blood Sugar
If you have type 2 diabetes, continue checking your blood glucose as advised and report unusual changes.
Inform About Other Medicines
Tell your healthcare professional about all medicines, vitamins, and supplements you take to help identify possible interactions.
Maintain a Healthy Lifestyle
Follow your recommended eating plan and physical activity routine to support blood fat and glucose management.
Attend Follow-Up Tests
Regular blood tests may help monitor triglycerides, cholesterol, liver function, and overall treatment response.
Note: Confirm the strength and instructions on your Bilypsa Tablet packaging and follow the guidance provided for your specific product.
Usage
How to Take Bilypsa Tablet
Bilypsa Tablet contains saroglitazar 4 mg. Take it according to the product instructions and your healthcare professional’s guidance.
Follow the Recommended Schedule
Take the tablet at the advised time each day. Do not change the dose or stop treatment without consulting your healthcare professional.
Maintain Regular Monitoring
Blood tests may be recommended to monitor triglycerides, cholesterol, blood glucose, and liver function during treatment.
Missed Dose
If you miss a dose, follow the instructions provided with your medicine or ask your healthcare professional. Do not take an extra dose to make up for a missed one.
Support Treatment With Healthy Habits
Follow your recommended eating plan, stay physically active, and attend scheduled follow-up appointments to support blood fat and glucose management.
Uses
Helps Manage High Triglycerides
Bilypsa Tablet contains saroglitazar, which helps reduce elevated triglyceride levels in adults with diabetic dyslipidemia.
Supports Lipid Balance
It helps improve abnormal blood fat levels, including triglycerides and certain other lipid measurements.
Helps Manage Diabetic Dyslipidemia
Bilypsa Tablet is used in adults with type 2 diabetes who have abnormal lipid levels, as part of an appropriate treatment plan.
Supports Fat Metabolism
Saroglitazar acts on receptors involved in fat metabolism, helping the body regulate blood lipid levels.
Supports Overall Metabolic Management
Bilypsa Tablet may be included alongside recommended lifestyle changes and other treatments to help manage metabolic health.
Note: Bilypsa Tablet is not a replacement for diabetes care, a balanced eating plan, or regular monitoring. Use it according to healthcare professional guidance.
Side Effects
Bilypsa Tablet contains saroglitazar, which may cause side effects in some people. The effects can vary depending on individual health and response to treatment.
Stomach discomfort: Mild abdominal discomfort may occur.
Nausea: Some people may experience an unsettled stomach.
Weakness: You may feel unusually tired or low in energy.
Digestive changes: Changes in digestion may occur in some individuals.
Liver-Related Concerns
Saroglitazar treatment may require liver function monitoring. Inform your healthcare professional if you notice unusual fatigue, yellowing of the skin or eyes, or dark-coloured urine.
Blood Sugar Changes
If you also take medicines for diabetes, monitor your blood glucose as advised and report unusual readings or symptoms.
When to Seek Medical Advice
Contact a healthcare professional if side effects persist or interfere with daily activities. Seek prompt medical attention for severe abdominal pain, yellowing of the eyes or skin, or other concerning symptoms.
FAQs
What is Bilypsa Tablet?
Bilypsa Tablet contains saroglitazar 4 mg, used to manage abnormal blood fat levels in adults with diabetic dyslipidemia.
How does Bilypsa Tablet work?
It acts on receptors involved in fat and glucose metabolism, helping reduce elevated triglycerides.
How should Bilypsa Tablet be taken?
Take it according to the product instructions and your healthcare professional’s guidance.
Does Bilypsa Tablet help manage cholesterol?
It primarily helps manage elevated triglycerides and may improve other lipid measurements.
Can Bilypsa Tablet be taken with diabetes medicines?
It may be used as part of a broader treatment plan, but your healthcare professional should review your medicines and monitoring needs.
What monitoring may be needed?
Blood tests may be used to check triglycerides, cholesterol, glucose levels, and liver function.
Is Bilypsa Tablet a replacement for lifestyle changes?
No. A balanced eating plan, physical activity, and regular monitoring remain important for metabolic health.
Interactions
Bilypsa Tablet contains saroglitazar, which affects fat and glucose metabolism. Share your current medicine list with your healthcare professional to help identify possible interactions and monitoring needs.
Diabetes Medicines
If you take other medicines to manage blood glucose, your healthcare professional may recommend monitoring your glucose levels and reviewing your overall treatment plan.
Cholesterol-Lowering Medicines
Inform your healthcare professional if you take statins, fibrates, or other medicines for abnormal blood fat levels. Your treatment combination may need review.
Liver-Affecting Medicines
Tell your healthcare professional about medicines that may affect liver function, as monitoring may be needed during treatment.
Herbal Products and Supplements
Share details of vitamins, herbal remedies, and nutritional supplements you use, as their effects and possible interactions may vary.
Alcohol
Discuss alcohol consumption with your healthcare professional, particularly if you have diabetes, abnormal blood fat levels, or liver-related concerns.
Other Prescription Medicines
Provide a complete list of your medicines, including those taken occasionally, so your healthcare professional can assess the overall treatment plan.
Regular Monitoring
Follow recommendations for blood glucose, lipid levels, and liver function tests. Do not stop or change any medicine without professional guidance.
Note: Specific interaction data for saroglitazar may be limited. These are general medicine-review points, not confirmation that every combination causes a direct interaction.
| Manufacturer | : | Zydus Lifesciences Limited |
| Equivalent Brand | : | |
| Generic Search | : | Saroglitazar |























